The 10-second takeaway
For the quarter ended Nov. 30 (Q2), AngioDynamics met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share contracted significantly.
Margins dropped across the board.
AngioDynamics recorded revenue of $87.0 million. The five analysts polled by S&P Capital IQ expected net sales of $87.2 million on the same basis. GAAP reported sales were 50% higher than the prior-year quarter's $58.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.10. The six earnings estimates compiled by S&P Capital IQ anticipated $0.09 per share. GAAP EPS of $0.06 for Q2 were 33% lower than the prior-year quarter's $0.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 50.7%, 650 basis points worse than the prior-year quarter. Operating margin was 8.5%, 70 basis points worse than the prior-year quarter. Net margin was 2.3%, 170 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $87.8 million. On the bottom line, the average EPS estimate is $0.09.
Next year's average estimate for revenue is $355.7 million. The average EPS estimate is $0.40.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 99 members out of 113 rating the stock outperform, and 14 members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give AngioDynamics a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on AngioDynamics is hold, with an average price target of $13.50.
Is AngioDynamics the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add AngioDynamics to My Watchlist.